uniQure N.V. (QURE) Form 10-Q Quarterly Reports
uniQure N.V. (QURE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: QURE
CIK: 1590560
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG Accountants N.V.
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerJohannes Geerts
Audit LocationAmstelveen, Netherlands
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-16 | — | SCHEDULE 13G/A Filing | 0000019617-26-000387 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-29 | FORM 8-K | 0001104659-26-111654 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-09-02 | 8-K | 0001104659-26-104463 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001446580-26-000102 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001493215-26-000163 | View SEC Doc Filr Page |
| S-8 | 2026-07-29 | — | S-8 | 0001104659-26-087822 | View SEC Doc Filr Page |
| 10-Q | 2026-07-29 | 2026-06-30 | 10-Q | 0001104659-26-087815 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | 8-K | 0001104659-26-087808 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-20 | — | SCHEDULE 13G/A Filing | 0001716774-26-000019 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-16 | — | SCHEDULE 13G Filing | 0000019617-26-000251 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | PRIMARY DOCUMENT | 0000904454-26-000397 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0000904454-26-000394 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0000904454-26-000392 | View SEC Doc Filr Page |
| 144 | 2026-07-02 | — | 144 Filing | 0001973379-26-000264 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | PRIMARY DOCUMENT | 0000904454-26-000387 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001973379-26-000261 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001973379-26-000260 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | PRIMARY DOCUMENT | 0000904454-26-000375 | View SEC Doc Filr Page |
| 144 | 2026-06-26 | — | 144 Filing | 0001973379-26-000259 | View SEC Doc Filr Page |
| 144 | 2026-06-25 | — | 144 Filing | 0001973379-26-000254 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-23 | FORM 8-K | 0001104659-26-077339 | View SEC Doc Filr Page |
| 424B5 | 2026-06-24 | — | 424B5 | 0001104659-26-077336 | View SEC Doc Filr Page |
| 144 | 2026-06-24 | — | 144 Filing | 0001973379-26-000252 | View SEC Doc Filr Page |
| 424B5 | 2026-06-22 | — | 424B5 | 0001104659-26-076466 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | PRIMARY DOCUMENT | 0000904454-26-000372 | View SEC Doc Filr Page |